(Clockwise, top left) Samuel F. Bakhoum, MD, PhD, Karlene A. Cimprich, PhD, Stephen P. Jackson, PhD, and David Pellman, PhD, discussed its viability as a novel therapy target.
Updates on phase III trials came from (clockwise, top left) Matthew J. Matasar, MD, Jessica Hassel, MD, Patrick M. Forde, MBBCh, and Georgina V. Long, PhD, MBBS.
Program Committee Chair Charles Swanton, MBPhD, FAACR, shares some of his selections from the day’s sessions to help plan your Annual Meeting experience.
(Clockwise, from top left) Katelyn T. Byrne, PhD, Brett G.M. Hughes, MSci, MBBS, Sanaz N. Ghafouri, MD, Jason Alan Chesney, MD, PhD, and Richard S. Finn, MD, will present during the session.
Presenters (from left) Sean J. Morrison, PhD, Leonard I. Zon, MD, and Iannis Aifantis, PhD, will also participate in a live panel and Q&A session on Monday on the same topics.
Presenters (clockwise, from top left): Jonathan Weissman, PhD, Karen Vousden, PhD, FAACR, Matthew Vander Heiden, MD, PhD, Melissa Davis, PhD, Mark Dawson, MD, PhD, and Zhijan James Chen, PhD.
The American Association for Cancer Research honored several cancer researchers, physician-scientists, advocates, and policymakers for their achievements during the Annual Meeting.
Subscribe below to get email updates from AACRMeetingNews.org